Novavax (NVAX) Assets Average (2011 - 2026)

Novavax's Assets Average history runs 16 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Assets Average fell 22.21% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (down 22.21% YoY), while the FY2025 annual figure was $1.4 billion, down 18.49% from the prior year.
• Assets Average was $1.1 billion for Q1 2026 at Novavax, down from $1.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.7 billion in Q2 2022 to a low of $1.1 billion in Q1 2026.
• Historically, Assets Average has averaged $1.8 billion across 5 years, with a median of $1.6 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Assets Average rose 29.13% in 2022, then slumped 40.86% in 2023.
• A 5-year view of Assets Average shows it stood at $2.3 billion in 2022, then fell by 23.67% to $1.7 billion in 2023, then fell by 5.26% to $1.6 billion in 2024, then declined by 28.0% to $1.2 billion in 2025, then dropped by 5.8% to $1.1 billion in 2026.
• The last three Assets Average figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.